Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.270
-0.070 (-1.61%)
At close: Sep 25, 2026, 4:00 PM EDT
4.340
+0.070 (1.64%)
Pre-market: Sep 28, 2026, 4:47 AM EDT
Immuneering Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
57
Market Cap
276.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 316.95K | -1.76M | -84.76% |
| Dec 31, 2021 | 2.08M | -231.57K | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fulcrum Therapeutics | 80.00M |
| Clinuvel Pharmaceuticals | 65.05M |
| Invivyd | 58.37M |
| Q32 Bio | 53.74M |
| Sutro Biopharma | 45.70M |
| Fate Therapeutics | 6.49M |
| Vicore Pharma Holding AB | 412.09K |
| InflaRx | -11.54K |
IMRX News
- 3 days ago - Immuneering to Present at the ESMO Congress 2026 - GlobeNewsWire
- 13 days ago - Immuneering Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 17 days ago - Immuneering Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 17 days ago - Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib's Dual Mechanism for Extended Survival - GlobeNewsWire
- 24 days ago - Immuneering to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Immuneering says FDA approval of pancreatic cancer treatment ‘good news’ - TheFly
- 4 weeks ago - Immuneering Comments on Today's FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients - GlobeNewsWire
- 7 weeks ago - Immuneering initiated with a Buy at H.C. Wainwright - TheFly